Iconac MR 8 Tablet is a combination analgesic and anti-inflammatory medication containing Thiocolchicoside 8 mg, Aceclofenac 100 mg, and Paracetamol 500 mg. Thiocolchicoside acts as a muscle relaxant by selectively inhibiting gamma-aminobutyric acid (GABA) and glycine receptors, thereby alleviating muscle spasms and associated pain. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts potent anti-inflammatory, analgesic, and antipyretic effects through the inhibition of cyclooxygenase enzymes (COX-1 and COX-2), leading to decreased prostaglandin synthesis. Paracetamol contributes additional analgesic and antipyretic benefits by inhibiting central prostaglandin synthesis, enhancing pain relief and fever reduction. This combination is indicated for the management of musculoskeletal pain associated with conditions such as osteoarthritis, rheumatoid arthritis, low back pain, and soft tissue injuries where muscle spasm and inflammation coexist. Iconac MR 8 provides effective symptomatic relief by targeting multiple pain pathways, improving patient mobility and quality of life. It should be used under medical supervision, considering contraindications such as hypersensitivity to any components, active gastrointestinal bleeding, or severe hepatic or renal impairment. Caution is advised in patients with cardiovascular risk factors or history of peptic ulcer disease. The dosage regimen should be individualized based on clinical response and tolerability.